This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69841844
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artículu científicu espublizáu en xunu de 1968 наукова стаття, опублікована в червні 1968 scientific article published on 01 June 1968 im Juni 1968 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q69841844-BC2DF5FD-C715-48FF-A327-5EF82E358BFB
wdt:P577
1968-06-01T00:00:00Z
p:P407
wds:Q69841844-08143641-F09A-44FB-9E6E-E24F0357F096
wdt:P407
wd:Q1860
p:P2093
wds:Q69841844-B2FBEE92-C3D6-4BE0-9169-8BC80CA25439 wds:Q69841844-584E7385-9005-4DB4-B87F-B111B2AC6893
wdt:P2093
H H Young J R Kent
rdfs:label
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment Plasma testosterone levels in patients with prostatic carcinoma before and after treatment
skos:prefLabel
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment Plasma testosterone levels in patients with prostatic carcinoma before and after treatment
schema:name
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment Plasma testosterone levels in patients with prostatic carcinoma before and after treatment
p:P1476
wds:Q69841844-BAD5EAF6-2944-49F7-B268-B5AA894B7004
wdt:P1476
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment
p:P304
wds:Q69841844-5D94CD93-5B3F-4C83-92DB-47C264DF9D8A
wdt:P304
788-792
p:P31
wds:Q69841844-F9456312-F6B7-4A12-BD42-6F583DE44784
wdt:P31
wd:Q13442814
p:P921
wds:Q69841844-61314AE3-AB01-4B25-9DE5-78924517ED43 wds:Q69841844-78BB44BC-A712-448B-8E3F-C42800B42B30
wdt:P921
wd:Q1318776 wd:Q27863114
p:P698
wds:Q69841844-05C476A6-8CE2-4870-BE6C-52DA196B5028
wdtn:P698
n12:4871357
wdt:P698
4871357
p:P1433
wds:Q69841844-8CEA1657-359E-4EAC-A214-B07A08BFDC1D
wdt:P1433
wd:Q15709979
p:P433
wds:Q69841844-4892755B-8235-4972-A904-9E9C968D8FCD
p:P478
wds:Q69841844-C1576FB6-DF27-48CF-B05B-FDF0C254933C
wdt:P433
6
wdt:P478
99
p:P356
wds:Q69841844-8E465445-8678-40F2-B322-8D7C4CC1CBF0
wdtn:P356
n9:S0022-5347(17)62795-2
wdt:P356
10.1016/S0022-5347(17)62795-2